Project Details
Description
A Phase 2/3 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Efficacy, Safety and Tolerability of BHV-7000 in Subjects with Refractory Focal Onset Epilepsy.
| Status | Active |
|---|---|
| Effective start/end date | 13.08.2024 → 31.01.2027 |
Fields of science
- 302052 Neurology